CorMedix CRMD Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's change in accrued liabilities?
- CorMedix (CRMD) reported change in accrued liabilities of -$50.62M in Q1 2026.
- How has CorMedix's change in accrued liabilities changed year-over-year?
- CorMedix's change in accrued liabilities decreased by 17436.3% year-over-year, from $292K to -$50.62M.
- What is the long-term trend for CorMedix's change in accrued liabilities?
- Over 2 years (2023 to 2025), CorMedix's change in accrued liabilities has grown at a 480.0% compound annual growth rate (CAGR), from $3M to $100.77M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.